Scarica l'app Stockscreener
6.88
2.38%
0.16
Dopo l'orario di chiusura:
6.97
0.09
+1.31%
Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie
From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch - marketscreener.com
LIXTE Biotechnology sings deal to acquire 100% of NOMAD to meet grid demand - MSN
LIXT Transforms from Biotech to Power Infrastructure Amid AI Dem - GuruFocus
LIXT Enters Agreement to Acquire Nomad Transportable Power Syste - GuruFocus
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, Pivots to Energy Storage - MEXC
The New Bottleneck Isn’t Computing Power — It’s Just Power - lincolnjournal.com
Lixte Biotechnology to acquire NOMAD Power Systems - Investing.com
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS) - The Manila Times
LIXTE Biotechnology Holdings, Inc. to Acquire NOMAD Transportable Power Systems, Inc. and Rebrand as NOMAD Power Solutions - Quiver Quantitative
Mobile grid batteries for AI boom: LIXTE to acquire NOMAD BESS leader - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
LIXTE to acquire NOMAD Transportable Power Systems for BESS pivot - grafa.com
Lixte Biotechnology Holdings (LIXT) Advances 3.3% as Investors Eye Key Resistance at $7.21Low Vol ETF - newsline.com
Lixte Biotechnology (NASDAQ:LIXT) holders report 5.1% stake in company - Stock Titan
Lixte Biotechnology Holdings, Inc. (LIXT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Lixte Biotechnology Announces At-the-Market Equity Financing - TipRanks
Lixte Biotechnology Raises $16.6 Million in Registered Direct Offering of Stock and Pre-Funded Warrants - TradingView
Lixte (NASDAQ: LIXT) closes $16.6M registered direct stock sale - Stock Titan
Lixte (NASDAQ: LIXT) sells 2.37M shares and 258,859 pre-funded warrants for $16.6M - Stock Titan
Lixte Biotechnology raises $16.6 million in direct offering - Investing.com UK
LIXTE Biotechnology prices $16.6M registered direct offering - MSN
Lixte Biotechnology stock falls after $16.6M capital raise By Investing.com - Investing.com Canada
Lixte Biotechnology stock falls after $16.6M capital raise - Investing.com
Lixte Biotechnology raises $16.6 million in direct offering By Investing.com - Investing.com Australia
Lixte Biotechnology Holdings, Inc. (LIXTW) Stock Price, News, Quote & History - Yahoo! Finance Canada
LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth - The Manila Times
LIXTE Biotechnology Announces $16,566,027 Registered Direct - GlobeNewswire
Lixte Biotechnology Prices $16.6 Million Registered Direct Offering Priced at the Market - Moomoo
LIXTE shifts to AI energy infrastructure, adds Porter to board By Investing.com - Investing.com Australia
LIXTE shifts to AI energy infrastructure, adds Porter to board - Investing.com UK
LIXTE (LIXT) director receives 25,000 RSU equity grant - Stock Titan
LIXTE (LIXT) director Stuart D Porter files Form 3 with no trades - Stock Titan
Lixte shifts from cancer drugs to AI energy infrastructure By Investing.com - Investing.com South Africa
LIXTE Biotechnology Transforms into AI Energy Infrastructure Company, Adds Denham Capital Founder to Board - MEXC
Lixte Biotechnology Converts to AI Energy Infrastructure Platform - Let's Data Science
LIXTE Biotechnology Announces Strategic Transformation Into AI Energy Infrastructure Equipment & Services - Moomoo
Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure - TipRanks
LIXTE Biotechnology Transforms Into AI Energy Infrastructure Company, Appoints Denham Capital’s Stuart D. Porter to Board - Minichart
Lixte Biotechnology Holdings Inc. announced a major strategic transformation, shifting its business focus to the field of artificial intelligence energy infrastructure equipment and services. - Bitget
Lixte shifts from cancer drugs to AI energy infrastructure - Investing.com
Lixte appoints Stuart D. Porter to its Board, term through 2026 annual meeting - TradingView
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):